Marker Therapeutics, Inc.
MRKR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001094038
No open-market purchases or sales by Marker Therapeutics, Inc. insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $5.84M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Marker Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −2 vs. Q3 2023
- Shares held
- 1.98M
- +35.7K (+1.8%) vs. Q3 2023
- Total value
- $10.9M
- +$2.05M (+23.3%) vs. Q3 2023
- New holders
- 0
- 6 more added
- Sold out
- 2
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRKR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $5.84M |
| Q1 2026 | 35 | $5.07M |
| Q4 2025 | 36 | $6.03M |
| Q3 2025 | 32 | $3.09M |
| Q2 2025 | 31 | $5.22M |
| Q1 2025 | 32 | $5.04M |
| Q4 2024 | 33 | $11.0M |
| Q3 2024 | 28 | $5.67M |
| Q2 2024 | 28 | $10.9M |
| Q1 2024 | 28 | $8.52M |
| Q4 2023 | 26 | $10.9M |
| Q3 2023 | 28 | $8.82M |
| Q2 2023 | 29 | $5.78M |
| Q1 2023 | 30 | $1.41M |
| Q4 2022 | 48 | $5.21M |
| Q3 2022 | 47 | $7.54M |
| Q2 2022 | 50 | $7.35M |
| Q1 2022 | 52 | $10.3M |
| Q4 2021 | 65 | $25.1M |
| Q3 2021 | 63 | $44.7M |
| Q2 2021 | 74 | $75.8M |
| Q1 2021 | 74 | $56.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Marker Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 31 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 12 | $66 | 0.00% | 00.0% | Unchanged |
| Versant Capital Management, Inc | 15 | $83 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 33 | $182 | 0.00% | −801−96.0% | Reduced |
| Huntington National Bank | 70 | $385 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 178 | $979 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 283 | $1.56K | 0.00% | +3+1.1% | Added |
| US Bancorp | 839 | $4.62K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,312 | $7.22K | 0.00% | +685+109.3% | Added |
| BlackRock Inc. | 1,364 | $7.50K | 0.00% | 00.0% | Unchanged |
| Riggs Asset Managment Co. Inc. | 1,600 | $8.80K | 0.00% | −750−31.9% | Reduced |
| Bank of America Corp | 2,334 | $12.8K | 0.00% | −886−27.5% | Reduced |
| Morgan Stanley | 3,598 | $19.8K | 0.00% | +1,658+85.5% | Added |
| Advisor Group Holdings, Inc. | 6,385 | $35.1K | 0.00% | −4,027−38.7% | Reduced |
| Matrix Asset Advisors Inc | 15,000 | $82.5K | 0.01% | 00.0% | Unchanged |
| Creative Planning | 17,312 | $95.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,748 | $108.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 20,278 | $111.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 37,550 | $207.0K | 0.00% | −2,700−6.7% | Reduced |
| Northern Trust Corp | 38,711 | $212.9K | 0.00% | +27,830+255.8% | Added |
| Geode Capital Management, LLC | 60,047 | $330.3K | 0.00% | 00.0% | Unchanged |
| Wedbush Securities Inc | 69,500 | $382.0K | 0.02% | +11,438+19.7% | Added |
| Ar Asset Management Inc | 70,700 | $389.0K | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 225,057 | $1.24M | 0.00% | +3,975+1.8% | Added |
| Aisling Capital Management LP | 314,286 | $1.73M | 0.52% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,071,428 | $5.89M | 0.39% | 00.0% | Unchanged |
| MCF Advisors LLC | 0 | $0 | 0.00% | −609−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −93−100.0% | Sold out |